ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

Dial Access Offers Caner Consultation Services

February 21, 1975

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks

July 30, 1982

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005